Arnold J describes SPC system as 'dysfunctional'

Arnold J has handed down a judgment referring yet another SPC question to the CJEU in GlaxoSmithKline Biologicals SA v Comptroller [2013] EWHC 619 (Pat). The referral relates to GSK’s applications for SPCs on an adjuvant (AS03) that it has developed alone, and in combination with an influenza virus antigen.

Previous case law of the CJEU (Pharmacia, MIT and Yissum) suggests that adjuvants are not “active ingredients” and so do not come within the definition of “product” in Article 1(b) of Council Regulation 469/2009/EC (the SPC Regulation) and cannot be the subject of a certificate. On the other hand, in order to give effect to the overriding objective of the SPC Regulation - that is to encourage research - Neurim interpreted “product” more broadly by including a purpose within the definition…

If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.

 

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer

Overview

5 New Street Square
London
EC4A 3TW
UK
http://www.taylorwessing.com

Turnover (£m): 228.00
No. of lawyers: 860
Jurisdiction: UK
No. of offices: 4
No. of qualified lawyers: 67 (International 50)

Jobs